OpenAlex · Aktualisierung stündlich · Letzte Aktualisierung: 12.03.2026, 06:36

Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.

Artificial Intelligence-Derived Age as a Predictor of Cardiovascular Morbidity and Mortality in an Obstetric Population: Results From the SPEC-AI Nigeria Randomized Clinical Trial [ID 1565]

2025·0 Zitationen·Obstetrics and Gynecology
Volltext beim Verlag öffnen

0

Zitationen

6

Autoren

2025

Jahr

Abstract

INTRODUCTION: The SPEC-AI Nigeria trial (NCT05438576) was designed to use artificial intelligence (AI) to screen for pregnancy-related cardiomyopathy in the peripartum period. Using data from this study, we evaluated the utility of AI-predicted delta age (adjusted AI-predicted age − chronological age) as a surrogate for biological age. METHODS: We included 1,187 pregnant and postpartum women enrolled between August 2022 and September 2023 with follow-up through May 2024. Standard 12-lead electrocardiograms (ECGs) were recorded at study entry to generate AI age predictions. Artificial intelligence-predicted age was adjusted using estimated reference ranges obtained from a community-dwelling cohort of 25,144 individuals with AI-ECG age estimated and documented chronological age. Logistic and Cox-proportional hazards regression were used to examine associations with comorbid cardiovascular conditions and maternal mortality, respectively. RESULTS: Adjusted AI-predicted age was significantly higher among women with any cardiovascular condition, peripartum cardiomyopathy, or who died within 18 months (7, 14, and 23 years older, respectively) compared to those without these conditions who had values similar to the normal reference ranges (adjusted AI-predicted age difference less than 1 year). Artificial intelligence-predicted delta age greater than the 75th percentile was associated with an odds ratio (OR) of 2.06 for any cardiovascular condition, OR of 4.98 for left ventricular systolic dysfunction, and a hazard ratio of 32.81 for all-cause mortality; all values of P <.001. CONCLUSIONS/IMPLICATIONS: Artificial intelligence-ECG-derived biological age appears to be a potentially useful measure of cardiovascular health status and risk among pregnant and postpartum women. However, its role in monitoring maternal health requires further exploration.

Ähnliche Arbeiten